A new report documents how cities around the world are becoming more liveable and sustainable in the face of climate change.

The woman's lawyers say the legal action alleges Queensland Health's Director-General David Rosengren improperly exercised his power when he issued a directive suspending the treatments, including ...

DMT induces rapid antidepressant effects, but acute sympathomimetic side effects, particularly hypertension and tachycardia, limit its use. This study describes coformulations with short-acting ...

A mother of a trans teenager has successfully taken the first step in legal action against the Queensland Health Director-General over the state's freeze on puberty blockers. The woman, whose name ...

Natural beta-blockers, found in many fruits, vegetables, and supplements, function similarly by reducing blood pressure but may have different mechanisms of action.

How Do They Work? Propranolol and metoprolol are beta-blockers. Beta-blockers block the action of epinephrine (also known as adrenaline), a substance produced in the body that can increase heart rate ...

An “unethical” NHS puberty blocker trial has been threatened with legal action by campaigners. Lawyers acting for Keira Bell, a former patient of the Tavistock Clinic, which was shut down amid ...

Beta-blocker drugs -- commonly used to treat heart and blood pressure issues -- may slow the progression of Huntington's disease (HD), according to a new study.

TUESDAY, Nov. 12, 2024 (HealthDay News) -- Beta blockers are go-to meds for many people who've survived a heart attack. However, new Swedish research has found that they might not be needed for heart ...

Beta Blockers Unnecessary for Folks Without Heart Failure; May Be Linked to Depression By Ernie Mundell HealthDay Reporter TUESDAY, Nov. 12, 2024 (HealthDay News) -- Beta blockers are go-to meds ...

Beta blockers are a class of medications commonly prescribed for a variety of cardiovascular conditions, including hypertension, heart rhythm disorders, and heart failure. While they are effective in ...

The ABYSS Trial To explore this issue, the open-label, non-inferiority ABYSS trial randomly assigned 3698 patients with a history of MI to the discontinuation or continuation of beta-blocker ...